Türkiye Health Tourism 2025-2026: International Patient Numbers and Revenue
- 23 Sep 2026
What do Türkiye’s 2025 and 2026 health-tourism figures show?
Türkiye has developed into a large international healthcare destination. In 2025, 1,398,580 people visited Türkiye to receive healthcare services, while health-tourism revenue reached USD 3,022,452 thousand, or approximately USD 3.022 billion. In the second quarter of 2026, 563,327 people visited for healthcare services and health-tourism revenue reached USD 1,579,518 thousand, approximately USD 1.580 billion.
These figures show market scale, but they do not replace individual medical assessment. For an international patient, the practical questions are which medical specialty is relevant, whether the hospital or clinic is authorised for the service, whether the physician has appropriate expertise, what the treatment plan includes, how travel and accommodation should be scheduled, and how follow-up will work after returning home. Clinicly focuses on coordinating these parts of the patient journey.
2025: fewer visitors, but revenue remained almost unchanged
In 2024, 1,506,442 people travelled to Türkiye for healthcare services and health-tourism revenue reached USD 3,022,957 thousand. In 2025, the number of visitors decreased to 1,398,580, while revenue remained almost flat at USD 3,022,452 thousand. The visitor count fell by roughly 7.2%, whereas the change in total revenue was minimal.
When total revenue and visitor numbers are viewed together, the aggregate revenue per visitor appears to have increased. This should not be treated as the price of a particular operation or treatment. Health-tourism revenue is an aggregated indicator that reflects different medical specialties, patient profiles, procedures and related travel expenditure.
Health-tourism revenue trend from 2015 to 2026
The long-term series shows a significant expansion in Türkiye’s health-tourism revenue. The figures below are stated in thousands of US dollars:
2015: USD 745,916 thousand
2016: USD 811,721 thousand
2017: USD 910,088 thousand
2018: USD 1,007,239 thousand
2019: USD 1,459,132 thousand
2020: USD 1,371,189 thousand
2021: USD 2,016,262 thousand
2022: USD 2,206,750 thousand
2023: USD 3,006,092 thousand
2024: USD 3,022,957 thousand
2025: USD 3,022,452 thousand
2026 Q2: USD 1,579,518 thousand
Revenue rose from USD 745.916 million in 2015 to about USD 3.022 billion in 2025, representing roughly a fourfold increase in scale over the decade. After the contraction in 2020, the market recovered strongly between 2021 and 2023, while 2024 and 2025 remained broadly stable around the USD 3.02 billion level.
How should the 2026 Q2 figure be interpreted?
The 2026 figures of 563,327 visitors and USD 1,579,518 thousand in revenue are not full-year figures. They are interim figures for the second-quarter period. Comparing them directly with the full-year 2025 total to calculate annual growth or decline would therefore be misleading. The full-year picture can change as later reporting periods are completed.
For patients, the main takeaway is that Türkiye receives a high volume of international healthcare visitors. Market size, however, does not prove that a particular hospital, physician or procedure is suitable for an individual. Medical suitability and treatment decisions must be based on a personal clinical assessment.
Which treatments are frequently searched for in Türkiye?
International patients commonly research plastic and aesthetic surgery, hair transplantation, dental treatments and implants, laser eye surgery and other ophthalmic treatments, orthopaedics and traumatology, cardiology, oncology and comprehensive health screening in Türkiye. Search popularity should not be confused with medical suitability; the appropriate treatment must be determined by qualified healthcare professionals after assessment.
What should international patients check before travelling?
Share your diagnosis, existing test results and medical history before treatment planning.
Confirm that the hospital or clinic is authorised to provide the relevant service.
Review the physician’s specialty, professional experience and suitability for the planned procedure.
Request a clear treatment plan covering the procedure, possible additional interventions, hospital stay and follow-up.
Clarify exactly what the quoted price includes and which items may create additional costs.
Plan flights, transfers and accommodation around the medical procedure and expected recovery period.
Agree in advance on post-treatment follow-up, communication in case of complications and the plan after returning home.
How does Clinicly support the international patient journey?
Clinicly helps people planning to travel from different countries to Türkiye for healthcare organise the non-clinical and coordination aspects of the journey. This can include understanding the patient’s needs, evaluating relevant specialty and provider options, coordinating appointments, supporting travel and accommodation planning, and maintaining communication around follow-up.
Clinicly does not diagnose patients or make treatment decisions in place of a physician. Medical suitability, risks, alternatives and the treatment method are determined by the relevant healthcare professionals. Keeping this distinction clear supports transparent and responsible health-tourism planning.
Frequently asked questions
How many people visited Türkiye for healthcare in 2025?
The number of people visiting Türkiye to receive healthcare services in 2025 was 1,398,580.
How much health-tourism revenue did Türkiye generate in 2025?
Health-tourism revenue reached USD 3,022,452 thousand, approximately USD 3.022 billion, in 2025.
Do the 2026 figures represent the full year?
No. The figures of 563,327 visitors and USD 1,579,518 thousand in revenue relate to the second-quarter reporting period and are not a full-year total.
How has Türkiye’s health-tourism revenue changed over the decade?
Revenue increased from USD 745.916 million in 2015 to approximately USD 3.022 billion in 2025, an increase in scale of roughly four times.
Does Clinicly decide which treatment a patient should have?
No. Clinicly supports healthcare-travel coordination. Diagnosis, medical suitability and treatment decisions are made by qualified physicians.
Conclusion
More than 1.39 million healthcare visitors and approximately USD 3.022 billion in revenue in 2025 demonstrate the scale of Türkiye’s international healthcare market. The second-quarter 2026 figures provide a further interim view of continuing patient mobility. A successful medical journey, however, depends on more than choosing a destination: it requires careful provider evaluation, a clear clinical plan, realistic travel arrangements and reliable follow-up. Clinicly supports international patients in organising these elements of their healthcare journey in Türkiye in a more structured and understandable way.
